Astra’s Blockbuster Drug Scores Major Win in Bladder Cancer

15-09-2024 02:30 0.5 Minutes reading Negative -1.00
AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the blockbuster medicine.

Related by source